Water for Injection System: Purified Water and WFI Design

Water for Injection System Basics: Grades and Where Each Is Used

Pharmacopoeias set standards for several grades of water, and each grade fits a defined set of uses. The EMA guideline on the quality of water for pharmaceutical use lists Water for Injections (WFI), Purified Water and Water for preparation of extracts as the European Pharmacopoeia grades. Potable water has no monograph but is the prescribed source feed water for the pharmacopoeial grades. The grade a product needs follows its intended use and the stage at which the water is used.

WHO's guideline adds the role of the top grade. Bulk water for injections (BWFI) should meet the relevant pharmacopoeial specifications for chemical and microbiological purity, including endotoxins, and it is the highest quality of pharmacopoeial water for pharmaceutical use. BWFI is not a final dosage form. It is an intermediate bulk product used as an ingredient and for final rinses of equipment that contacts injectable products. Our guide to parenteral formulation development explains where this water enters the product.

Once the grade is chosen, the next question is how the water is made.

Purified Water System Pharma Design: Pretreatment, RO, EDI and Distillation

Every pharmacopoeial grade starts from drinking water, so the generation train begins with pretreatment. The WHO guideline on water for pharmaceutical use makes the manufacturer responsible for assuring that the source water meets drinking-water requirements. It lists desalination, filtration, softening, disinfection by ozone or sodium hypochlorite, iron removal and precipitation as typical drinking-water processes. It also asks for controls on microbial growth in sand filters, carbon beds and softeners, such as backflushing, sanitisation and regeneration.

The route to WFI changed in 2017. EMA reports that the Ph. Eur. monograph 0169 was revised, effective 1 April 2017, to allow a purification process equivalent to distillation, such as reverse osmosis coupled with electro-deionisation, ultrafiltration or nanofiltration. The USP wording allows distillation or a process proven equivalent or superior to distillation, and the Japanese Pharmacopoeia allows distillation or reverse osmosis and ultrafiltration. EMA asks manufacturers to notify the GMP supervisory authority before introducing reverse osmosis at a site. WHO's guideline on production of water for injection by means other than distillation asks for a risk assessment and a control strategy covering each life-cycle stage.

Generation only matters if the water reaches the user points in the same condition, which is the job of the loop.

Pharmaceutical Water Loop Design: Materials, Dead Legs and Storage

The loop is where most pharmaceutical water systems fail, because it is where water sits in contact with materials for hours. WHO asks that components stay suitable across the full range of temperature and pressure, at rest, in operation and during sanitisation. Distribution should be designed as a loop with continuous circulation, and a one-way system needs a justification and robust monitoring. Filtration should not be used in distribution loops or at user take-off points.

Storage vessels add their own requirements. WHO asks for vessels that drain, with spray balls or distributors that wet the inner surfaces and prevent stagnant water in the headspace. Vents carry bacteria-retentive hydrophobic filters with integrity testing, and pressure relief devices have external rupture indicators so that a loss of integrity is detected. Heat exchangers sit in circulating loops, and double tube sheet or double plate designs should be considered. Our guide to GMP facility design for pharmaceutical manufacturing places the utility room within the wider plant.

Even a perfect loop needs a way to control microbial growth over time, which is sanitisation.

Pharmaceutical Water Loop Sanitisation: Thermal, Chemical and Ultraviolet Control

Sanitisation controls the bioburden that no design can fully exclude. WHO asks that treatment, storage and distribution systems be subject to controls that reduce contamination and microbial proliferation. Procedures can be chemical, thermal or both, and the conditions, times, temperatures and frequency must be defined and proven effective for every relevant part of the system. The technique has to be chosen at the design stage because it affects the components and materials.

The temperature choice has a practical consequence. WHO notes that when lower temperatures are needed because of the treatment process or the use temperature, special precautions must prevent the ingress of microorganisms. It also asks that any cooling for processing happen for the minimum necessary time, with the cooling cycles proven satisfactory during qualification. Ambient systems such as ion exchange and ultrafiltration need sanitisation at intervals set by validation data, because static periods raise the contamination risk.

Controls only count once the system has been qualified and is monitored for the long term.

Water System Qualification: Three-Phase Validation and Continuous Monitoring

Water systems are qualified and validated because water is used before its microbiological result is known. WHO describes qualification stages that can include the user requirement specification, factory and site acceptance tests, and installation, operational and performance qualification. Commissioning is documented but is not a replacement for qualification. The scope of the work follows a risk assessment, and the quality unit approves release at the appropriate stage.

Monitoring continues after validation. WHO asks for a combination of online and offline instruments linked to qualified alarms, with flow, pressure and temperature monitored online, and conductivity and TOC online where possible. Offline testing confirms the online results and covers microbiological attributes. For WFI made by non-distillation methods, the WHO guideline encourages rapid microbiological methods and asks for TOC and conductivity to be monitored with online instruments. Results are analysed statistically at defined intervals, held within control limits such as 3 sigma, and used to set alert and action levels from historical data.

Developers do not build these systems alone, but they define what the system must deliver.

Water Systems and Formulation: What Developers Need to Specify

A formulation team owns the water grade even when engineering owns the pipework. The EMA guideline says the grade used at different stages should be discussed in the marketing authorisation application and should take account of the product and the stage of use. WHO's lists of design inputs read as a user requirement specification checklist. Writing that checklist early avoids a utility that is the wrong size or the wrong grade for the pipeline.

1. Grade by use — name the grade for each use: ingredient, granulation, coating, lyophilisation, cleaning and final rinse.
2. Quantity — define minimum, average and maximum demand, including peaks.
3. Feed water — record the quality of the drinking-water feed and its variation over the seasons.
4. Specification — set the required quality and alert and action levels from data.
5. Points of use — decide the number and location of sampling points and user take-offs.
6. Sanitisation strategy — choose thermal, chemical or combined, with the materials chosen to match.
7. Instrumentation and data — specify TOC, conductivity, flow, pressure and temperature, plus data integrity and audit trail.

EMA's tables set WFI for formulation before sterile lyophilisation and purified water before non-sterile lyophilisation, and our guide to pharmaceutical lyophilisation covers the process itself. Our guide to the FDA, ICH and USP regulatory pathway covers how such choices are documented in a filing.

Choosing a partner who can carry this through is the last decision.

Working With a Pharmaceutical Formulation Consultant and CDMO

Pharmaceutical water sits between formulation, utilities engineering, microbiology and regulation, so a decision in one area affects the others. A pharmaceutical formulation consultant maps each water use to its grade, drafts the user requirements and reviews the qualification plan. Pharmaceutical product development services extend that into stability design, specifications and regulatory documentation. Contract formulation CDMO support then relies on a partner whose water system is qualified, monitored and reviewed on a documented schedule.

1. Map water uses — grade for each ingredient, process and rinse step.
2. Draft the user requirements — demand, feed water, specification and points of use.
3. Review the design — materials, loop, dead legs, storage and sanitisation.
4. Plan qualification — phases, sampling points and alert and action levels.
5. Assess a CDMO's system — qualification status, trend data, annual review and deviation history.
6. Document the grade — record the water grade and rationale in the regulatory file.

Our pharmaceutical and healthcare range shows where water-dependent dosage forms sit. Our guide to choosing a pharmaceutical formulation consultant explains how to select a partner. Global Formulation provides water grade selection, requirement drafting, qualification review and CDMO assessment support for pharmaceutical developers. Pharmacopoeial limits, site-specific operating setpoints and proprietary designs stay outside this guide by design.